| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Russell Angus C. is a Director at Lineage Cell Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 6 buys and 1 sell.
Estimated insider holdings value: $130K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | LCTX Lineage Cell Therapeutics, Inc. | - | Sale+OE | 4,720 | $2.97 | $14,018.40 | -5.1% | -8.9% | -45.1% | |
| Aug 23, 2019 | TXMD Therapeuticsmd, Inc. | Director | Buy | 10,000 | $2.77 | $27,700.00 | +12.0% | - | - | |
| Aug 15, 2019 | TXMD Therapeuticsmd, Inc. | Director | Buy | 35,000 | $2.83 | $98,900.00 | +28.7% | - | - | |
| Nov 6, 2015 | LCTX Lineage Cell Therapeutics, Inc. | Director | Buy | 50,000 | $3.83 | $191,500.00 | +285.7% | - | - | |
| Aug 25, 2015 | TXMD Therapeuticsmd, Inc. | Director | Buy | 13,500 | $5.98 | $80,784.00 | +38.6% | - | - | |
| May 12, 2015 | TXMD Therapeuticsmd, Inc. | Director | Buy | 35,000 | $6.15 | $215,316.50 | New | - | - |